Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA seeks comments on nutrition facts study, food survey

This article was originally published in The Tan Sheet

Executive Summary

The agency requests comments on two separate proposed studies - "Experimental Study of Nutrition Facts Label Formats" and "Real Time Surveys of Consumers' Knowledge, Perceptions, and Reported Behavior Concerning Food-borne Illness Outbreaks or Food Recalls," according to Nov. 18 Federal Register notices. The nutrition facts study aims to "quantitatively assess consumer reactions to potential options for modifying the Nutrition Facts label format." The Web-based food-borne illness survey seeks the reactions and knowledge of outbreaks and food recalls of approximately 30,000 U.S. consumers. FDA will use the information to "adjust its communication strategies and messages for food-borne illness outbreaks or food recalls." FDA seeks comments on whether the proposals are necessary, suggestions for improving the study/survey design and whether the agency's cost estimates are accurate

You may also be interested in...

Chloroquine ‘Approval’ For COVID-19 And The US FDA’s New Reality

Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.

Biopharma, Payers Seek National Guidelines For Prescribing Potential COVID-19 Drugs

Guidelines for health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.

Becton Dickinson, BioMedomics Collaborate On Rapid Serology COVID-19 Test

BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts